Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
News
Article
2023 SDPA Fall Conference Recap: Day 4
Author(s):
Catch up on coverage from the fourth and final day of the 2023 SDPA Fall Dermatology Conference.
jdross75/Adobe Stock
Study Reveals HCPs Underestimate Burden of Disease Associated With Seborrheic Dermatitis
The study was presented in a poster at the 2023 SDPA Fall Conference in Nashville, TN.
Understanding Itchy Dermatoses: Pearls and Best Practices
Ted Rosen, MD, presented a session comprehensively discussing common dermatoses characterized by itch and pruritus.
Mark Lebwohl, MD: The Evolving Treatment Landscape of IL-17 Inhibitors
Mark Lebwohl, MD, spoke with Dermatology Times about his talk on IL-17 inhibitors.
Individualized Treatment Considerations for Adult Women With Acne
Allison Arthur, MD, discussed the importance of tailoring a treatment plan for adult women with acne vulgaris that best suits their lifestyle and current needs.
Make sure to keep up to date with the latest in coverage from the conference and subscribe to Dermatology Times to receive daily email updates.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Videos
Related Content
